190 related articles for article (PubMed ID: 28239467)
1. CCR7
Kueberuwa G; Gornall H; Alcantar-Orozco EM; Bouvier D; Kapacee ZA; Hawkins RE; Gilham DE
J Immunother Cancer; 2017; 5():14. PubMed ID: 28239467
[TBL] [Abstract][Full Text] [Related]
2. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
[TBL] [Abstract][Full Text] [Related]
3. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy with redirected T cells produces CCR7- cells that are trapped in the periphery and benefit from combined CD28-OX40 costimulation.
Hombach AA; Chmielewski M; Rappl G; Abken H
Hum Gene Ther; 2013 Mar; 24(3):259-69. PubMed ID: 23350854
[TBL] [Abstract][Full Text] [Related]
5. A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy.
Ren H; Cao K; Wang M
Front Immunol; 2021; 12():745109. PubMed ID: 34603332
[TBL] [Abstract][Full Text] [Related]
6. The road to memory: an early rest for the long journey.
Ho LP; Yit PS; Ng LH; Linn YC; Zhao Y; Sun L; Ling KL; Chai Koh MB; Monica Shih MC; Li S; Wang XY; Tien SL; Goh YT
J Immunol; 2013 Dec; 191(11):5603-14. PubMed ID: 24184558
[TBL] [Abstract][Full Text] [Related]
7. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
Takata H; Takiguchi M
J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
[TBL] [Abstract][Full Text] [Related]
9. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy.
Powell DJ; Dudley ME; Robbins PF; Rosenberg SA
Blood; 2005 Jan; 105(1):241-50. PubMed ID: 15345595
[TBL] [Abstract][Full Text] [Related]
10. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells.
Schwendemann J; Choi C; Schirrmacher V; Beckhove P
J Immunol; 2005 Aug; 175(3):1433-9. PubMed ID: 16034079
[TBL] [Abstract][Full Text] [Related]
11. Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.
Wang X; Berger C; Wong CW; Forman SJ; Riddell SR; Jensen MC
Blood; 2011 Feb; 117(6):1888-98. PubMed ID: 21123821
[TBL] [Abstract][Full Text] [Related]
12. Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
de Jager SC; Canté-Barrett K; Bot I; Husberg C; van Puijvelde GH; van Santbrink PJ; Yndestad A; van den Oever JM; Kuiper J; van Berkel TJ; Lipp M; Zwaginga JJ; Fibbe WE; Aukrust P; Biessen EA
Transplantation; 2009 Sep; 88(5):631-9. PubMed ID: 19741459
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of CCR4+ and CCR6+ memory T-cells including CCR7+CD45RAmed very early memory cells in granulomatosis with polyangiitis (Wegener's).
Fagin U; Pitann S; Gross WL; Lamprecht P
Arthritis Res Ther; 2012 Apr; 14(2):R73. PubMed ID: 22490506
[TBL] [Abstract][Full Text] [Related]
14. CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma.
Schomer NT; Jiang ZK; Lloyd MI; Klingemann H; Boissel L
Cytotherapy; 2022 Aug; 24(8):827-834. PubMed ID: 35400595
[TBL] [Abstract][Full Text] [Related]
15. Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype.
Gargett T; Truong N; Ebert LM; Yu W; Brown MP
Cytotherapy; 2019 Jun; 21(6):593-602. PubMed ID: 30975603
[TBL] [Abstract][Full Text] [Related]
16. Transient stimulation expands superior antitumor T cells for adoptive therapy.
Kagoya Y; Nakatsugawa M; Ochi T; Cen Y; Guo T; Anczurowski M; Saso K; Butler MO; Hirano N
JCI Insight; 2017 Jan; 2(2):e89580. PubMed ID: 28138559
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients' bone marrow.
Cao H; Kim DH; Howard A; Moz H; Wasnik S; Baylink DJ; Chen CS; Reeves ME; Mirshahidi S; Xiao J; Francis O; Marcucci G; Xu Y
Neoplasia; 2021 Dec; 23(12):1252-1260. PubMed ID: 34775232
[TBL] [Abstract][Full Text] [Related]
18. Curtailed T-cell activation curbs effector differentiation and generates CD8
Zanon V; Pilipow K; Scamardella E; De Paoli F; De Simone G; Price DA; Martinez Usatorre A; Romero P; Mavilio D; Roberto A; Lugli E
Eur J Immunol; 2017 Sep; 47(9):1468-1476. PubMed ID: 28671275
[TBL] [Abstract][Full Text] [Related]
19. Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7.
Unsoeld H; Pircher H
J Virol; 2005 Apr; 79(7):4510-3. PubMed ID: 15767451
[TBL] [Abstract][Full Text] [Related]
20. IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.
Alizadeh D; Wong RA; Yang X; Wang D; Pecoraro JR; Kuo CF; Aguilar B; Qi Y; Ann DK; Starr R; Urak R; Wang X; Forman SJ; Brown CE
Cancer Immunol Res; 2019 May; 7(5):759-772. PubMed ID: 30890531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
